Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma

Prostate-specific membrane antigen (PSMA), whose high expression has been demonstrated in metastatic aggressive prostate adenocarcinoma, is also highly expressed in the neovessels of various solid tumors, including clear cell renal cell carcinoma (ccRCC). In the VISION phase III clinical trial, PSMA...

Descripción completa

Detalles Bibliográficos
Autores principales: Giraudet, Anne Laure, Vinceneux, Armelle, Pretet, Valentin, Paquet, Emilie, Lajusticia, Alicia Sanchez, Khayi, Fouzi, Badel, Jean Noël, Boyle, Helen, Flechon, Aude, Kryza, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383345/
https://www.ncbi.nlm.nih.gov/pubmed/37513907
http://dx.doi.org/10.3390/ph16070995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383345/
https://www.ncbi.nlm.nih.gov/pubmed/37513907
http://dx.doi.org/10.3390/ph16070995

Ejemplares similares